The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus
Abstract
CONTEXT: Visfatin (also known as pre-B cell colony-enhancing factor or PBEF) is a cytokine that is highly expressed in visceral fat and whose blood levels correlate with obesity. Originally isolated as a secreted factor that promotes the growth of B cell precursors and recently found to act as an insulin analog on the insulin receptor, its pathophysiological role in humans remains largely unknown. OBJECTIVES: In this study we investigated whether plasma visfatin level is altered in patients with type 2 diabetes mellitus (T2DM). DESIGN AND PATIENTS: Plasma visfatin as well as adiponectin and resistin concentrations were measured through ELISA in type 2 diabetic and nondiabetic subjects. RESULTS: A total of 61 patients with T2DM and 59 sex- and age-matched nondiabetic subjects were studied. Plasma visfatin was found to be elevated in patients with T2DM (31.9 +/- 31.7 vs. 15.8 +/- 16.7 ng/ml, P = 0.002). In contrast, adiponectin was decreased (4.3 +/- 2.5 vs. 30.8 +/- 10.3 microg/ml, P < 0.001), whereas plasma resistin level did not differ between the groups. Increasing concentrations of visfatin were independently and significantly associated with T2DM. Multiple logistic regression analysis revealed visfatin as an independent association factor for T2DM, even after full adjustment of known biomarkers. The association between adiponectin and T2DM was no longer significant after adjustments for body mass index or waist to hip ratio. In a multiple linear regression analysis, only waist to hip ratio was independently associated with plasma visfatin level. CONCLUSION: Our results indicate that visfatin may play a role in the pathogenesis of T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Regulation of Fasted Blood Glucose by Resistin
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., et al. (2004) · Science · doi:10.1126/science.1092341 · Cited by 725
Jia, S. H., Li, Y., Parodo, J., Kapus, A., Fan, L., Rotstein, O. D., & Marshall, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19930 · Cited by 598
Plasma Adiponectin Concentrations Predict Insulin Sensitivity of Both Glucose and Lipid Metabolism
Tschritter, O., Fritsche, A., Thamer, C., Haap, M., Shirkavand, F., Rahe, S., Staiger, H., Maerker, E., Häring, H., & Stumvoll, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.239 · Cited by 585
Savage, D. B., Sewter, C. P., Klenk, E. S., Segal, D. G., Vidal-Puig, A., Considine, R. V., & O’Rahilly, S. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2199 · Cited by 572
Lee, J. H., Chan, J. L., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030519 · Cited by 548
Regulation of adipocytokines and insulin resistance
Fasshauer, M., & Paschke, R. (2003) · Diabetologia · doi:10.1007/s00125-003-1228-z · Cited by 545
The current biology of resistin
Steppan, C. M., & Lazar, M. A. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01306.x · Cited by 373
Age of Onset and Type of Diabetes
Laakso, M., & Pyörälä, K. (1985) · Diabetes Care · doi:10.2337/diacare.8.2.114 · Cited by 245
Insulin Resistance in Type 2 Diabetes - Role of the Adipokines
Arner, P. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766022 · Cited by 201
Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes
Ognjanovic, S., & Bryant-Greenwood, G. D. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126295 · Cited by 191
Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease
Chen, M.-P., Tsai, J. C.-R., Chung, F.-M., Yang, S.-S., Hsing, L.-L., Shin, S.-J., & Lee, Y.-J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000157784.25920.a7 · Cited by 168
Self-citationSzopa, M., & Dembinska-Kiec, A. (2005) · Jagiellonian University Repository (Jagiellonian University) · Cited by 166
Identification of a Plasmid-Encoded Gene from Haemophilus ducreyi Which Confers NAD Independence
Martin, P. R., Shea, R. J., & Mulks, M. H. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.4.1168-1174.2001 · Cited by 165
Obesity, hypertension and insulin resistance
Sharma, A. M., & Chetty, V. T. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0175-1 · Cited by 153
Lee, Y., & Tsai, J. C. ‐. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1002 · Cited by 144
Self-citationB, J. R. V. B., Moerkerk, P. T. M., Gerbers, A. J., A, A. P. D. B., Arends, J., Hoogenboom, H. R., & Hufton, S. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10584 · Cited by 134
Peripheral Total and Differential Leukocyte Count in Diabetic Nephropathy
Chung, F., Tsai, J. C. ‐., Chang, D., Shin, S., & Lee, Y. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1710 · Cited by 116
Self-citationResistin: an adipocyte‐derived hormone. Has it a role in diabetes and obesity?
Rea, R., & Donnelly, R. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00334.x · Cited by 104
Identification and Characterization of Differentially Expressed Genes in Denervated Muscle
Tang, H., Cheung, W. M. W., Ip, F. C. F., & Ip, N. Y. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0864 · Cited by 68
Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus
Kim, M. J., Yoo, K. H., Park, H.-S., Chung, S.-M., Jin, C.-J., Lee, Y., Shin, Y.-G., & Chung, C. H. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.1.42 · Cited by 35
Self-citationBloomgarden, Z. T. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2342 · Cited by 35
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
Moschen, A. R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., & Tilg, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1748 · Cited by 933
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 808
Metadata
- Authors
- Chen, M.-P., Chung, F.-M., Chang, D.-M., Tsai, J. C.-R., Huang, H.-F., Shin, S.-J., & Lee, Y.-J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-01
- Volume
- 91
- Issue
- 1
- Pages
- 295-299
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1989200821
- Cited by
- 660
- References
- 30
- FWCI
- 44.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.